共 50 条
- [5] Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis [J]. EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 494 - 502
- [7] Androgen deprivation therapy ± new antihormonal therapy for the treatment of metastatic hormone-sensitive prostate cancer [J]. UROLOGIE, 2023, 62 (04): : 354 - 359
- [9] Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer [J]. UROLOGIE, 2023, 62 (04): : 360 - 368
- [10] EFFICACY AND FEASIBILITY OF ADDITIONAL CYCLES OF DOCETAXEL IN COMBINATION WITH ANDROGEN DEPRIVATION THERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER [J]. JOURNAL OF UROLOGY, 2023, 209 : E388 - E389